Amgen to Stop Offering Discounts on Anemia Drug

August 28th, 2008

The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product?s safety.

Posted by Filed in Anemia, Amgen Inc|AMGN|NASDAQ, Rebates, Decisions and Verdicts, Johnson & Johnson Inc, Prices (Fares, Fees and Rates), Suits and Litigation, Cancer, Drugs (Pharmaceuticals)

Leave a Reply

Linki sponsorowane teksty hosting ser gry dla dzieci GPC News | auto nauka | encyklopedia 420 | auto lektury | auto aktywa | gimnastyka auto | motywator | auto raxo | Projekty Domow Cash for gold leasing Teksty piosenek autogiełda, ogłoszenia samochodowe, ogłoszenia mot